Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias (HPV)
Primary Purpose
Cervical Intraepithelial Neoplasia, Human Papilloma Virus
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Local Hyperthermia at 37℃
LEEP or cold knife
Local Hyperthermia at 44℃
Sponsored by
About this trial
This is an interventional treatment trial for Cervical Intraepithelial Neoplasia focused on measuring hyperthermia, human papillomavirus virus, cervical intraepithelial neoplasia
Eligibility Criteria
Inclusion Criteria:
- 18-65 years old; generally healthy gynecological conditions, normal sexual life; high risk HPV; Cervical biopsy CIN or no cytological changes; signed informed consent
Exclusion Criteria:
- Pregnant woman;local or systematic treatment within 3 months; Comorbidity of other severe gynecological inflammation, infection, or tumor; Comorbidity of other serious illnesses; no guarantee of timely treatment and follow-up
Sites / Locations
- Yang Yang
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Sham Comparator
Active Comparator
Experimental
Arm Label
Local Hyperthermia at 44℃ for HPV+/CIN-1
local hyperthermia at 37℃ for 30 mins
coniztion of the cervix treatment
Local Hyperthermia at 44℃ for CIN2/HPV+
Arm Description
Local hyperthermia at 44℃ for 30 mins on cervical region, at days of 1,2,3 and 17, 18. HPV+ and normal cytology or HPV+/CIN-1
HPV+/CIN-1
coniztion of cervix for HPV+/CIN2, including LEEP or cold knife coniztion
Local hyperthermia at 44℃ for 30 mins at days of 1,2,3 and 17, 18. HPV+ and CIN2.
Outcomes
Primary Outcome Measures
clearance rates of HPV
to evaluate the clearance rates in different treatment groups 3 month after treatment.
scoring atypia by cytology/pathology
to evaluate atypia severity score of cervical cells 3 month after treatment.
Secondary Outcome Measures
viral load measurement
to measure the HPV 16 viral load after 3 month of treatment
Full Information
NCT ID
NCT03436251
First Posted
July 22, 2017
Last Updated
August 17, 2021
Sponsor
First Hospital of China Medical University
1. Study Identification
Unique Protocol Identification Number
NCT03436251
Brief Title
Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias
Acronym
HPV
Official Title
Evaluation of Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias After 3 Months: a Multicenter, Single-blind, Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
January 28, 2018 (Actual)
Primary Completion Date
May 8, 2020 (Actual)
Study Completion Date
August 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
First Hospital of China Medical University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Human papillomavirus(HPV) infect epithelial cells and have the capacity to stimulate cell abnormal hyperplasia, especially by those high-risk HPV types. HPV vaccine primarily targeting HPV6/11/16/18 has been available and makes it possible to prevent cervical cancer. However, a large population was left unvaccinated, specifically for those aged ones. In clinic, patients harboring high-risk HPV is quite prevalent in China or other developing nations. Removing the virus and prevention of malignant transformation is required.
Mild local Hyperthermia with a certain temperature range has been successfully used in the treatment of some diseases. It has been utilised in the treatment of some neoplasm, fungal and HPV infections. Investigators' study found that local hyperthermia at 44°C could cleared HPV in more than half of the patients with plantar warts. Investigators also note the fact that in patients with multiple lesions, the clearance of the target lesion is commonly followed by clearance of other distant lesions, a phenomenon suggesting that local hyperthermia could aid in establishing a specific immune response to eliminate HPV.So the purpose of the study is to evaluation local hyperthermia in the treatment of cervical intraepithelial neoplasias grade I and II after 3 months, with positive high-risk type HPVs, and patients with positive testing for high risk HPVs. Appropriate control arms were designed for different conditions.
Detailed Description
Mild local Hyperthermia with a certain temperature range has been successfully used in the treatment of some diseases. It has been utilised in the treatment of some neoplasm, fungal and HPV infections. Investigators' study found that local hyperthermia at 44°C could cleared HPV in more than half of the patients with plantar warts. Investigators also note the fact that in patients with multiple lesions, the clearance of the target lesion is commonly followed by clearance of other distant lesions, a phenomenon suggesting that local hyperthermia could aid in establishing a specific immune response to eliminate HPV.So the purpose of the study is to evaluation local hyperthermia in the treatment of cervical intraepithelial neoplasias grade I and II after 3 months, with positive high-risk type HPVs, and patients with positive testing for high risk HPVs. Appropriate control arms were designed for different conditions. One control arm is local hyperthermia at 37°C for 30 mins targeted for CINⅠ, the other control arm is LEEP targeted for CINⅡ. After 3 months, to evaluate the effectivity of local hyperthermia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Intraepithelial Neoplasia, Human Papilloma Virus
Keywords
hyperthermia, human papillomavirus virus, cervical intraepithelial neoplasia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
53 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Local Hyperthermia at 44℃ for HPV+/CIN-1
Arm Type
Experimental
Arm Description
Local hyperthermia at 44℃ for 30 mins on cervical region, at days of 1,2,3 and 17, 18. HPV+ and normal cytology or HPV+/CIN-1
Arm Title
local hyperthermia at 37℃ for 30 mins
Arm Type
Sham Comparator
Arm Description
HPV+/CIN-1
Arm Title
coniztion of the cervix treatment
Arm Type
Active Comparator
Arm Description
coniztion of cervix for HPV+/CIN2, including LEEP or cold knife coniztion
Arm Title
Local Hyperthermia at 44℃ for CIN2/HPV+
Arm Type
Experimental
Arm Description
Local hyperthermia at 44℃ for 30 mins at days of 1,2,3 and 17, 18. HPV+ and CIN2.
Intervention Type
Device
Intervention Name(s)
Local Hyperthermia at 37℃
Intervention Description
As a control, for patients with HPV+/CIN-1 or HPV+ with normal cytology, hyperthermia at 37℃ is applied
Intervention Type
Device
Intervention Name(s)
LEEP or cold knife
Intervention Description
For patients with HPV+ / CIN-2
Intervention Type
Device
Intervention Name(s)
Local Hyperthermia at 44℃
Intervention Description
As an experimental arm, for patients with HPV+/CIN-1/CIN2 or HPV+ with normal cytology
Primary Outcome Measure Information:
Title
clearance rates of HPV
Description
to evaluate the clearance rates in different treatment groups 3 month after treatment.
Time Frame
3 months after the last time of treatment.
Title
scoring atypia by cytology/pathology
Description
to evaluate atypia severity score of cervical cells 3 month after treatment.
Time Frame
3 months after the last time of treatment.
Secondary Outcome Measure Information:
Title
viral load measurement
Description
to measure the HPV 16 viral load after 3 month of treatment
Time Frame
3 months after the last time of treatment.
10. Eligibility
Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18-65 years old; generally healthy gynecological conditions, normal sexual life; high risk HPV; Cervical biopsy CIN or no cytological changes; signed informed consent
Exclusion Criteria:
Pregnant woman;local or systematic treatment within 3 months; Comorbidity of other severe gynecological inflammation, infection, or tumor; Comorbidity of other serious illnesses; no guarantee of timely treatment and follow-up
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xinghua Gao
Organizational Affiliation
First Hospital of China Medical University
Official's Role
Study Director
Facility Information:
Facility Name
Yang Yang
City
Shenyang
State/Province
Liaoning
ZIP/Postal Code
110001
Country
China
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33905482
Citation
Yang Y, Zhang L, Zhang Y, Huo W, Qi R, Guo H, Li X, Wu X, Bai F, Liu K, Qiao Y, Piguet V, Croitoru D, Chen HD, Gao XH. Local Hyperthermia at 44 degrees C Is Effective in Clearing Cervical High-Risk Human Papillomaviruses: A Proof-of-Concept, Randomized Controlled Clinical Trial. Clin Infect Dis. 2021 Nov 2;73(9):1642-1649. doi: 10.1093/cid/ciab369.
Results Reference
derived
Learn more about this trial
Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias
We'll reach out to this number within 24 hrs